Joel Chick
Vice President, Proteomics Discovery RyboDyn
Experienced Scientist with a demonstrated history of working in the biotechnology industry. Skilled in , Proteomics, Chemo-Proteomics, Protein Purification, Molecular Biology, and Mass Spectrometry. Strong research professional that graduated from Macquarie University Doctoral Program. Has 7 years biotech industry experience at top biotech companies such as Vividion Therapeutics and Odyssey Therapeutics. Has 9 years research experience at Harvard Medical School and Dana Farber Cancer Institute. Proficient at running and maintaining mass spectrometry instruments and liquid chromatography systems. Has a strong publication record in top tier journals.
Seminars
Whilst proteomics has the potential to reveal the workings of the proteome and demystify disease signalling pathways, part of the story is still missing. Combining genomics, transcriptomics, and metabolomics insights to contextualize proteomics is vital to better understand pathology and guide therapeutic discovery.
This workshop will gather experts to discuss how to:
- Effectively harmonize and integrate genomics, transcriptomics, and metabolomics data to bolster understanding of proteomics and generate a more holistic view of pathology and therapeutic response
- Employ innovative computational and AI tools to streamline multi-omics workflows and maximize time and cost-efficiency of large-scale data analysis
- Apply multi-omics across drug discovery, from deconvoluting disease pathways and identifying novel targets to validating biomarkers and optimizing hit identification
